Craig Seaman
Experienced in Essential Thrombocythemia

Dr. Craig Seaman

Hematology
UPMC
Classical Hematology
3601 Fifth Ave, Falk Building, 3rd Floor, 
Pittsburgh, PA 
On Staff At
Accepting New Patients
Experienced in Essential Thrombocythemia
UPMC
Classical Hematology
3601 Fifth Ave, Falk Building, 3rd Floor, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Seaman is a Hematologist in Pittsburgh, Pennsylvania. Dr. Seaman is rated as an Experienced provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is currently accepting new patients.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Marshall University School Of Medicine
Residency
University of Pittsburgh School of Medicine
Specialties
Hematology
Licenses
Internal Medicine in PA
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Pittsburgh School of Medicine
Hospital Affiliations
Upmc Presbyterian Shadyside
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Classical Hematology
3601 Fifth Ave, Falk Building, 3rd Floor, Pittsburgh, PA 15213
Call: 412-586-9875

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Enrollment Status: Terminated
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: Von Willebrand Factor, Tranexamic Acid
Study Phase: Phase 3
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: April 11, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: February 21, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Factor Replacement Products
A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Factor Replacement Products
Enrollment Status: Completed
Publish Date: December 09, 2021
Intervention Type: Biological
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Enrollment Status: Withdrawn
Publish Date: August 20, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

26 Total Publications

Impact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWF.
Impact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWF.
Journal: Blood advances
Published: May 05, 2025
View All 26 Publications
Similar Doctors
Advanced in Essential Thrombocythemia
Dr. Hemamalini Karpurapu
Hematology Oncology | Hematology | Oncology
Advanced in Essential Thrombocythemia
Dr. Hemamalini Karpurapu
Hematology Oncology | Hematology | Oncology

Wmc Physician Practices LLC

601 Colliers Way, 
Weirton, WV 
 (30.3 miles away)
304-797-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hemamalini Karpurapu is a Hematologist Oncology specialist and a Hematologist in Weirton, West Virginia. Dr. Karpurapu is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Myelodysplastic Syndrome (MDS), and Familial Colorectal Cancer. Dr. Karpurapu is currently accepting new patients.

Advanced in Essential Thrombocythemia
Dr. Salman M. Fazal
Hematology Oncology | Hematology | Oncology
Advanced in Essential Thrombocythemia
Dr. Salman M. Fazal
Hematology Oncology | Hematology | Oncology

Allegheny Clinic

4815 Liberty Ave, 
Pittsburgh, PA 
 (1.3 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Salman Fazal is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Fazal is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelofibrosis, Aplastic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Advanced in Essential Thrombocythemia
Dr. Afaq Ahmad
Hematology Oncology | Hematology | Oncology
Advanced in Essential Thrombocythemia
Dr. Afaq Ahmad
Hematology Oncology | Hematology | Oncology

Hematology Oncology Association

200 Village Dr, 
Greensburg, PA 
 (28.0 miles away)
724-838-1900
Languages Spoken:
English
See accepted insurances

Afaq Ahmad is a Hematologist Oncology specialist and a Hematologist in Greensburg, Pennsylvania. Dr. Ahmad is rated as an Advanced provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Anemia, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

VIEW MORE ESSENTIAL THROMBOCYTHEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Seaman's expertise for a condition
ConditionClose
  • Elite
  • Hemophilia A
    Dr. Seaman is
    Elite
    . Learn about Hemophilia A.
    See more Hemophilia A experts
  • Von Willebrand Disease (VWD)
    Dr. Seaman is
    Elite
    . Learn about Von Willebrand Disease (VWD).
    See more Von Willebrand Disease (VWD) experts
  • Distinguished
  • Blood Clots
    Dr. Seaman is
    Distinguished
    . Learn about Blood Clots.
    See more Blood Clots experts
  • Hemophilia B
    Dr. Seaman is
    Distinguished
    . Learn about Hemophilia B.
    See more Hemophilia B experts
  • Hemophilic Arthropathy
    Dr. Seaman is
    Distinguished
    . Learn about Hemophilic Arthropathy.
    See more Hemophilic Arthropathy experts
  • Heyde Syndrome
    Dr. Seaman is
    Distinguished
    . Learn about Heyde Syndrome.
    See more Heyde Syndrome experts
  • Advanced
  • Acquired Hemophilia
    Dr. Seaman is
    Advanced
    . Learn about Acquired Hemophilia.
    See more Acquired Hemophilia experts
  • Bernard-Soulier Syndrome
    Dr. Seaman is
    Advanced
    . Learn about Bernard-Soulier Syndrome.
    See more Bernard-Soulier Syndrome experts
  • Glanzmann Thrombasthenia
    Dr. Seaman is
    Advanced
    . Learn about Glanzmann Thrombasthenia.
    See more Glanzmann Thrombasthenia experts
  • Gray Platelet Syndrome
    Dr. Seaman is
    Advanced
    . Learn about Gray Platelet Syndrome.
    See more Gray Platelet Syndrome experts
  • Platelet Storage Pool Deficiency
    Dr. Seaman is
    Advanced
    . Learn about Platelet Storage Pool Deficiency.
    See more Platelet Storage Pool Deficiency experts
  • Shwartzman Phenomenon
    Dr. Seaman is
    Advanced
    . Learn about Shwartzman Phenomenon.
    See more Shwartzman Phenomenon experts
View All 8 Advanced Conditions
  • Experienced
  • Acute Eosinophilic Pneumonia
    Dr. Seaman is
    Experienced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Anemia
    Dr. Seaman is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Antiphospholipid Syndrome
    Dr. Seaman is
    Experienced
    . Learn about Antiphospholipid Syndrome.
    See more Antiphospholipid Syndrome experts
  • Congenital Hemolytic Anemia
    Dr. Seaman is
    Experienced
    . Learn about Congenital Hemolytic Anemia.
    See more Congenital Hemolytic Anemia experts
  • Cryoglobulinemia
    Dr. Seaman is
    Experienced
    . Learn about Cryoglobulinemia.
    See more Cryoglobulinemia experts
  • Deep Vein Thrombosis
    Dr. Seaman is
    Experienced
    . Learn about Deep Vein Thrombosis.
    See more Deep Vein Thrombosis experts
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.